Ad
related to: mersana stock price
Search results
Results from the WOW.Com Content Network
The mean of analysts' price targets for Mersana Therapeutics, Inc. (MRSN) points to a 255.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong ...
The stock of Mersana Therapeutics (NAS:MRSN, 30-year Financials) gives every indication of being significantly overvalued, according to GuruFocus Value calculation.
Shares of biotech firm Mersana Therapeutics (MRSN) soared on Wednesday, closing up 69% to $18.19 per share. What was the cause
For premium support please call: 800-290-4726 more ways to reach us
In finance, market data is price and other related data for a financial instrument reported by a trading venue such as a stock exchange. Market data allows traders and investors to know the latest price and see historical trends for instruments such as equities, fixed-income products, derivatives, and currencies. [1]
Do the numbers hold clues to what lies ahead for the stock? Mersana Therapeutics, Inc. (MRSN) delivered earnings and revenue surprises of -10% and 34.72%, respectively, for the quarter ended June ...
Hedge funds' top 3 stock picks returned 41.7% this year and beat […] Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained 54% and 51% respectively.
It is based on market capitalisation. Weighting of shares is conducted in proportion to the issued ordinary capital of the listed companies, valued at current market price (i.e. market capitalisation). The base year is 1985, and the base value of the index is 100. This is the longest and the broadest measure of the Sri Lankan Stock market.
Ad
related to: mersana stock price